ONC201 (Dordaviprone) in Recurrent H3 K27M–Mutant Diffuse Midline Glioma Patients enrolled in the multicenter, randomized SYNCHRONOUS and CCRe-IV trials were included in the analysis. Patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results